S
Stockadora

Recent Annual Reports

Browse the latest SEC filings with AI-powered analysis. Get insights into corporate performance, financial trends, and business developments.

📊 4797 Reports
🤖 AI Analyzed
Recent
📄 Page 155 of 400
SEMTECH CORP
10-K March 23, 2026

Key Highlights

  • Achieved strong overall sales growth of 15.5% to $1.05 billion for fiscal year 2...
  • Saw robust growth in Signal Integrity (23.3%) and Analog Mixed Signal and Wirele...
  • Strategically acquired HieFo Corporation for $34 million to strengthen product o...
Read Analysis
🤖 AI Generated
PARKERVISION INC
10-K March 23, 2026

Key Highlights

  • Specialized in patenting and licensing core wireless technologies, operating as ...
  • Secured a favorable opinion and remand against Qualcomm in 2024, a positive step...
  • Holds 36 active U.S. and international RF patents, with expiration dates ranging...
Read Analysis
🤖 AI Generated
KiNRG, Inc.
10-K March 23, 2026

Key Highlights

  • Patented HydroThermal Reactor (HTR) technology offers carbon-free, 24/7/365 elec...
  • Strategic focus on high-demand markets: AI data centers (modular HTRs) and green...
  • Proprietary "Energy Calculator" and "off-the-shelf" components reduce technical ...
Read Analysis
🤖 AI Generated
AMERICAN EXPRESS CREDIT ACCOUNT MASTER TRUST
10-K March 20, 2026

Key Highlights

  • The Trust is a special financial arrangement that issues asset-backed securities...
  • It provides American Express with immediate cash from future credit card payment...
  • Credit card balances held by the Trust are diversified, with no single customer ...
Read Analysis
🤖 AI Generated
ARAUCO & CONSTITUTION PULP INC
20-F March 20, 2026

Key Highlights

  • Strategic investments exceeding $116 million in port facilities, forestry, and g...
  • Standardization of Brazilian companies' reporting currency to the U.S. Dollar fr...
  • Active portfolio management, including strategic divestments and reorganizations...
Read Analysis
🤖 AI Generated
QIAGEN N.V.
20-F March 20, 2026

Key Highlights

  • Reported $2.15 billion in total sales for 2025, a 3.5% increase from 2024, drive...
  • Adjusted profit per share increased by 7.7% to $2.10 in 2025, with profit for sh...
  • Strategic acquisitions of Parse Biosciences ($150M upfront) and GNX Data Systems...
Read Analysis
🤖 AI Generated
URBAN ONE, INC.
10-K March 20, 2026

Key Highlights

  • Strong 7.5% total revenue growth to $242.8 million in 2025, with increased profi...
  • Strategic acquisition of La Mega Media Inc. for $25 million, expanding radio pre...
  • Significant growth in the Digital segment (14.5%) and improved financial health ...
Read Analysis
🤖 AI Generated
Ceres Classic L.P.
10-K March 20, 2026

Key Highlights

  • Operates as a Limited Partnership, limiting investor risk to capital invested.
  • Engages in diversified trading of futures and forward contracts across numerous ...
  • Aims to profit from market movements using complex long/short strategies and lev...
Read Analysis
🤖 AI Generated
SWK Holdings Corp
10-K March 20, 2026

Key Highlights

  • Strategic shift towards streamlining business by selling non-core assets and dis...
  • Focus on core finance receivables and pharmaceutical development segments, poten...
  • Offers non-dilutive funding solutions to life sciences and healthcare companies,...
Read Analysis
🤖 AI Generated
OCULUS INC.
10-K March 20, 2026

Key Highlights

  • Addresses critical and growing markets: cybersecurity, data privacy, and data pr...
  • Experienced 25% sales growth in 2025, indicating early market traction for its p...
  • Undergoing a strategic product review to adapt to rapid technological changes, i...
Read Analysis
🤖 AI Generated
FORD CREDIT FLOORPLAN MASTER OWNER TRUST A
10-K March 20, 2026

Key Highlights

  • Independent audit (PwC) confirmed Ford Motor Credit LLC's compliance with all ke...
  • The Master Owner Trust structure efficiently securitizes dealership floorplan lo...
  • Asset-Backed Securities (ABS) issued by the Trust often carry high credit rating...
Read Analysis
🤖 AI Generated
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
10-K March 20, 2026

Key Highlights

  • Received crucial FDA approvals for clinical trials for Type 1 Diabetes and chron...
  • Granted Orphan Drug Designation (ODD) for ImmCelzâ„¢ for Brittle Type 1 Diabetes, ...
  • Reported positive early clinical data for StemSpine® (chronic lower back pain) a...
Read Analysis
🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from annual reports with our AI-powered analysis. Track corporate performance, financial trends, and strategic developments.

Back to Homepage